This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Bcl9l Antibodies
AND Bcl9l ELISA kits, Bcl9l Proteins
Many biological assays use antibodies to detect Bcl9l, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with Bcl9l in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop Bcl9l antibodies...
Designing an IHC experiment for Bcl9l? The guide has the expected staining pattern, antigen retrieval and fixation, antibodies backed by real IHC images, the tissue controls to run alongside, and protocols taken from published papers.
Open the BCL9L IHC GuideBcl9l Infographic by Boster Bio
All Bcl9l Products
Product
Figures
Specificity
Applications
Price
Anti-MIRO1/RHOT1 Antibody Picoband®
1 Citations
Human, Mouse, Rat
ELISA, IF, IHC, ICC, WB
$370
Cat # A05928-1
100 μg/vial
Cat # A05928-1
100 μg/vial
Human, Mouse, Rat
ELISA, Flow Cytometry, IHC, WB
$370
Cat # A05905
100 μg/vial
Cat # A05905
100 μg/vial
Mouse, Rat
ELISA, Flow Cytometry, IF, ICC, WB
$370
Cat # A05936-2
100 μg/vial
Cat # A05936-2
100 μg/vial
Human, Rat
ELISA, Flow Cytometry, IHC, WB
$370
Cat # A05916-1
100 μg/vial
Cat # A05916-1
100 μg/vial
Bcl9l Overview
Facts about B-cell CLL/lymphoma 9-like protein.
B-cell CLL/lymphoma 9-like protein (Bcl9l)
Transcriptional regulator that functions as an activator. Promotes beta-catenin transcriptional activity.
Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1.
Gene Information
| Mouse | |
|---|---|
| Gene Name: | Bcl9l |
| Uniprot: | Q67FY2 |
| Entrez: | 80288 |
Family
| Belongs to: |
|---|
| BCL9 family |
Alternative Names
B-cell CLL/lymphoma 9-like protein; B-cell CLL/lymphoma 9-like; B-cell lymphoma 9-like protein; Bcl92; Bcl9-2; BCL9-like protein; DLNB11; DLNB11BCL9-2; nuclear co-factor of beta-catenin signalling; Protein BCL9-2
Molecular Weight
Mass (kDA):
156.68 kDA
Genomic Context
| Mouse | |
|---|---|
| Location: | 9|9 A5.2 |
| Sequence: | 9; |
Tissue Specificity
Expressed in kidney, liver, lung, testis, brain, spleen, heart and skeletal muscle. Highly expressed in numerous colorectal tumors compared to corresponding non-cancerous tissues.
Diseases
- Malignant Neoplasms
- Neoplasms
- Carcinogenesis
- Neuroblastoma
- Colorectal Neoplasms
- Cell Transformation, Neoplastic
- Adenoma
- Carcinoma
- Mammary Neoplasms
- Adenocarcinoma
- Malignant Paraganglionic Neoplasm
- Neoplasm Metastasis
- Embryonal Carcinoma
Pathways
- Regeneration
- Tissue Homeostasis
- Tissue Regeneration
- Stem Cell Maintenance
- Immune Response
- Neurogenesis
- Cell Fate Determination
PTMs
- Phosphorylation
For details, visit:
bosterbio.com/bosterbio-gene-info-cards/Bcl9l
bosterbio.com/bosterbio-gene-info-cards/Bcl9l
References
PMID: 15574752 by Adachi S., et al. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
PMID: 15371335 by Brembeck F.H., et al. Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions.